NHS leaders are warning that the costs linked to ADHD and autism are becoming “out of control,” in a fresh sign of the pressure that growing demand for assessment, diagnosis and support is placing on services across England.
The warning comes as medical news outlets report that clinicians and health leaders are struggling to keep pace with an expanding need for neurodevelopmental care, an area that has increasingly shaped debates about access, waiting times and service capacity within the NHS. The issue has also become part of a broader conversation about how health systems should respond when demand rises faster than staffing and resources can adapt.
Pressure on assessment and support pathways
According to The BMJ’s report published on September 1, 2026, the latest concerns centre on the financial impact of rising ADHD and autism-related needs, with NHS leaders describing the situation as unsustainable. The development adds to ongoing scrutiny of specialist pathways that often involve multiple referrals, long waits and complex follow-up care.
While ADHD and autism are distinct conditions, both can require careful assessment, coordinated support and long-term planning. That places pressure not only on specialist clinics, but also on schools, families, mental health services and community teams that are expected to help manage care after diagnosis.
A growing challenge for health services
The latest warning reflects a wider theme seen across recent UK health reporting: the NHS is being asked to absorb more complex demand while operating under tight constraints. Neurodevelopmental services are often cited by clinicians as examples of care pathways where demand can rise rapidly, but the workforce and infrastructure needed to respond may not expand at the same speed.
For patients and families, that can mean uncertainty, delays and difficulty navigating services. For the NHS, it can mean mounting costs, difficult prioritisation decisions and increasing pressure on already stretched teams.
The BMJ’s reporting points to the issue as one that is likely to remain high on the health agenda, particularly as leaders seek ways to balance rising need with finite public resources. At the same time, the warning underscores how neurodevelopmental care has moved from a specialist concern to a major system-wide challenge.
As services continue to adapt, the central question for policymakers will be whether the NHS can build pathways that are both faster and more sustainable, without losing sight of the needs of patients who depend on them.
Photo source: AI-generated or edited image
